Diagnostics

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
COVID-19 Testing Lab In UK Misreported Several Positive Cases As Negative
EXCLUSIVE: Virax Biolabs Launches RSV/Flu/COVID-19 Combo Rapid Test Kit In Europe
COVID-19 Testing Lab In UK Misreported Several Positive Cases As Negative
EXCLUSIVE: Virax Biolabs Launches RSV/Flu/COVID-19 Combo Rapid Test Kit In Europe
Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests

Diagnostics Recent News

FDA Gives Nod To First Nonprescription COVID-19 Test That Also Detects Flu, RSV
Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance
UK-Based Start-Up Working On Next COVID-19 Vaccine Using Animal Feces: FT
Quest Diagnostics Secures CDC Contract To Support COVID-19 Research
Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated Minicapsules
Twist Bioscience Corporation (NASDAQ: TWST) has 
Manufacturing Bottlenecks Hit Launch Of Talis' FDA-Approved COVID-19 Test
Talis Biomedical Corp (NASDAQ: TLIS) said that it had 
Lucira Health Terminates COVID-19 Test-Related Patent Agreement With Eiken Chemical
Twist Bioscience, Eleven Therapeutics Create Synthetic Viral RNA Molecules To Develop Antiviral Vaccines, Therapeutics
Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication, antiviral drug screening, and vaccine & therapeutic development.
Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus
Medtronic Shares Fall After FDA Warning Letter To Its Diabetes Business
Medtronic Plc (NYSE: MDT) 
Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing
Applied DNA Sciences Inc (NASDAQ: APDN) reported a more than ninefold Y/Y increase in Q4 FY21 revenues, driven by the rise in clinical laboratory service revenues related to COVID-19 testing.
FDA Enlists Thermo Fisher, Google-Backed Verily COVID-19 Tests Likely To Be Affected By Omicron
On Friday, the 
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
President Biden announced that private health
FDA Reissues Emergency Use Authorization For LumiraDx's COVID-19 Testing Solution
The 
GBS Shares Are Rallying On Plans For COVID-19 Antibody Trials After Validation Study
GBS Inc (NASDAQ: GBS) 
Valneva Recruits IDT Biologika As Manufacturing Partner For Its COVID-19 Vaccine
Valneva SE (NASDAQ: VALN) and IDT Biologika have announced their collaboration to produce Valneva's inactivated COVID-19 vaccine candidate VLA2001. 
Chembio Diagnostics' DPP COVID-19 Antigen Test Approved In South Africa
South Africa Health Products Regulatory Authority (SAHPRA) has approved Chembio Diagnostics Inc's (NASDAQ: CEMI) DPP SARS-CoV-2 Antigen test for use at the point of care.
Applied DNA Stock Surges On Launch Plans For Linea 2.0 COVID-19 Assay For Omicron Variant
Applied DNA Sciences Inc (NASDAQ: APDN) 
Thermo Fisher Says Its COVID-19 Tests Can Detect Omicron Variant
​​​​​Thermo Fisher Scientific Inc (NYSE: TMO) said that its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron.
Qiagen Says Its COVID-19 PCR Tests Can Detect The New South African Variant
Qiagen N.V. (NYSE: QGEN) announced that its polymerase chain reaction (PCR) 
Chembio Files For FDA Emergency Use Nod For COVID-19 Antigen Test
Medicare Coverage For Natera's Signatera For Pan-Cancer Immunotherapy Monitoring
Why Are Talis Shares Trading Higher Today?

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved